Comparing the efficacy of stimulants for ADHD in children and adolescents using meta-analysis

European Child and Adolescent Psychiatry

Volumn 19, Issue 4, 2010, Pages 353-364

  Faraone, Stephen V ^a   Buitelaar, Jan ^b  

^a SUNY UPSTATE MEDICAL UNIVERSITY   (United States)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

ADHD; Effect size; Efficacy; Medications; Meta analysis

Indexed keywords

AMPHETAMINE; LONG ACTING DRUG; METHYLPHENIDATE; PLACEBO; SHORT ACTING DRUG;

ADOLESCENCE; ARTICLE; ATTENTION DEFICIT DISORDER; CLINICAL ASSESSMENT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DOPAMINERGIC TRANSMISSION; DRUG EFFICACY; DRUG SCREENING; EFFECT SIZE; HUMAN; META ANALYSIS; NEUROTRANSMISSION; PSYCHOLOGICAL RATING SCALE; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; TREATMENT RESPONSE;

ADOLESCENT; ADULT; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CENTRAL NERVOUS SYSTEM STIMULANTS; HUMANS; TREATMENT OUTCOME;

EID: 77950862209     PISSN: 10188827     EISSN: 1435165X     Source Type: Journal    
DOI: 10.1007/s00787-009-0054-3     Document Type: Article

References (50)

1. L Arnold 2000 Methylphenidate vs. amphetamine: comparative review J Atten Disord 3 200 211 10.1177/108705470000300403
2. LE Arnold J Christopher R Huestis DJ Smeltzer 1978 Methylphenidate vs dextroamphetamine vs caffeine in minimal brain dysfunction Arch Gen Psychiatry 35 463 473 1:STN:280:DyaE1M%2FotFGktw%3D%3D 365123
3. T Banaschewski D Coghill P Santosh A Zuddas P Asherson J Buitelaar M Danckaerts M Dopfner SV Faraone A Rothenberger J Sergeant HC Steinhausen EJ Sonuga-Barke E Taylor 2006 Long-acting medications for the hyperkinetic disorders: a systematic review and European treatment guideline Eur Child Adolesc Psychiatry 15 476 495 10.1007/s00787-006-0549-0 16680409 (Pubitemid 46020533)
4. J Biederman FA Lopez SW Boellner MC Chandler 2002 A randomized, double-blind, placebo-controlled, parallel-group study of SLI381 in children with attention deficit hyperactivity disorder Pediatrics 110 258 266 10.1542/peds.110.2.258 12165576 (Pubitemid 34833008)
5. Cohen J (1988) Statistical power analysis for the behavioral sciences. Erlbaum, Hillsdale
6. GA Colditz JN Miller F Mosteller 1988 Measuring gain in the evaluation of medical technology. The probability of a better outcome Int J Technol Assess Health Care 4 637 642 10.1017/S0266462300007728 1:STN:280:DyaL1M%2FnvFekuw%3D%3D 10291102
7. DJ Cox RL Merkel M Moore F Thorndike C Muller B Kovatchev 2006 Relative benefits of stimulant therapy with OROS methylphenidate versus mixed amphetamine salts extended release in improving the driving performance of adolescent drivers with attention-deficit/hyperactivity disorder Pediatrics 118 e704 e710 10.1542/peds.2005-2947 16950962 (Pubitemid 46089997)
8. R Dersimonian N Laird 1986 Meta-analysis in clinical trials Controlled Clin Trials 7 177 188 10.1016/0197-2456(86)90046-2 1:STN:280: DyaL2s7gsVamtA%3D%3D 3802833 (Pubitemid 17189972)
9. A Dlugos C Freitag C Hohoff J Mcdonald EH Cook J Deckert H De Wit 2007 Norepinephrine transporter gene variation modulates acute response to d-amphetamine Biol Psychiatry 61 1296 1305 10.1016/j.biopsych.2006.09.031 1:CAS:528:DC%2BD2sXls1aisro%3D 17239355 (Pubitemid 46726264)
10. S Duval R Tweedie 2000 A nonparametric "trim and fill" method of accounting for publication bias in meta-analysis J Am Stat Assoc 95 89 98 10.2307/2669529 (Pubitemid 30422636)
11. D Efron F Jarman M Barker 1997 Methylphenidate versus dexamphetamine in children with attention deficit hyperactivity disorder: a double-blind, crossover trial Pediatrics 100 E6 10.1542/peds.100.6.e6 1:STN:280: DyaK1czotVGlug%3D%3D 9382907 (Pubitemid 27425991)
12. M Egger G Davey Smith M Schneider C Minder 1997 Bias in meta-analysis detected by a simple, graphical test Br Med J 315 629 634 1:STN:280: DyaK2svls1KjtA%3D%3D (Pubitemid 27387172)
13. J Elia BG Borcherding JL Rapoport CS Keysor 1991 Methylphenidate and dextroamphetamine treatments of hyperactivity: are there true nonresponders? Psychiatry Res 36 141 155 10.1016/0165-1781(91)90126-A 1:STN:280: DyaK3M3gsVyqtw%3D%3D 2017529
14. J Elia P Welsh C Gullota J Rapoport 1993 Classroom academic performance: Improvement with both methylphenidate and dextroamphetamine in ADHD boys J Child Psychol Psychiatry Allied Disciplines 34 785 804 10.1111/j.1469-7610.1993. tb01071.x 1:STN:280:DyaK3szktVansw%3D%3D (Pubitemid 23204730)
15. S Faraone J Biederman 2002 Efficacy of adderall, for attention-deficit/ hyperactivity disorder: a meta-analysis J Atten Disord 6 69 75 10.1177/108705470200600203 1:STN:280:DC%2BD38zptl2gug%3D%3D 12142863 (Pubitemid 41749407)
16. S Faraone E Short J Biederman RL Findling CM Roe M Manos 2002 Efficacy of Adderall and Methylphenidate in attention deficit hyperactivity disorder: a drug-placebo and drug-drug response curve analysis of a naturalistic study Int J Neuropsychopharmacol 5 121 129 10.1017/S1461145702002845 1:CAS:528: DC%2BD3sXnsVequ7Y%3D 12135536 (Pubitemid 34662974)
17. SV Faraone J Biederman CM Roe 2002 Comparative efficacy of adderall and methylphenidate in attention-deficit/hyperactivity disorder: a meta-analysis J Clin Psychopharmacol 22 468 473 10.1097/00004714-200210000-00005 1:CAS:528:DC%2BD38Xntl2jsbg%3D 12352269 (Pubitemid 38134162)
18. SV Faraone J Biederman T Spencer D Michelson L Adler F Reimherr S Glatt 2005 Efficacy of atomoxetine in adult attention-deficit/hyperactivity disorder: a drug-placebo response curve analysis Behav Brain Funct 1 16 10.1186/1744-9081-1-16 16202140 (Pubitemid 44848779)
19. SV Faraone J Biederman TJ Spencer M Aleardi 2006 Comparing the efficacy of medications for ADHD using meta-analysis Medscape Gen Med E J 8 4 (Pubitemid 44541837)
20. SV Faraone J Biederman TJ Spencer TE Wilens 2000 The drug-placebo response curve: a new method for assessing drug effects in clinical trials J Clin Psychopharmacol 20 673 679 10.1097/00004714-200012000-00014 1:CAS:528:DC%2BD3cXos1OlsL0%3D 11106140
21. SV Faraone SR Pliszka RL Olvera R Skolnik J Biederman 2001 Efficacy of adderall and methylphenidate in attention-deficit/hyperactivity disorder: a drug-placebo and drug-drug response curve analysis J Child Adolesc Psychopharmacol 11 171 180 10.1089/104454601750284081 1:STN:280: DC%2BD38%2FhvVCgtg%3D%3D 11436957 (Pubitemid 32588489)
22. SV Faraone J Sergeant C Gillberg J Biederman 2003 The worldwide prevalence of ADHD: is it an American condition? World Psychiatry 2 104 113 16946911
23. SV Faraone T Spencer M Aleardi C Pagano J Biederman 2004 Meta-analysis of the efficacy of methylphenidate for treating adult attention deficit hyperactivity disorder J Clin Psychopharmacol 54 24 29 10.1097/01.jcp. 0000108984.11879.95 (Pubitemid 38134162)
24. C Green 1996 Methylphenidate vs dexamphetamine: a clinical audit J Paediatr Child Health 32 470 10.1111/j.1440-1754.1996.tb00954.x 1:STN:280:DyaK2s%2FoslCisA%3D%3D 8933415
25. LL Greenhill RL Findling JM Swanson 2002 A double-blind, placebo-controlled study of modified-release methylphenidate in children with attention-deficit/hyperactivity disorder Pediatrics 109 E39 10.1542/peds.109.3. e39 11875167
26. LL Greenhill S Pliszka MK Dulcan W Bernet V Arnold J Beitchman RS Benson O Bukstein J Kinlan J Mcclellan D Rue JA Shaw S Stock K Kroeger 2001 Summary of the practice parameter for the use of stimulant medications in the treatment of children, adolescents, and adults J Am Acad Child Adolesc Psychiatry 40 1352 1355 10.1097/00004583-200102000-00012 1:STN:280:DC%2BD3MnkslCmtw%3D%3D 11699811
27. JA Hanley BJ Mcneil 1982 The meaning and use of the area under a receiver operating characteristic (ROC) curve Radiology 143 29 36 1:STN:280: DyaL387ltFyksQ%3D%3D 7063747 (Pubitemid 12142173)
28. Hedges LV, Olkin I (1985) Statistical methods for meta-analysis. Academic Press, Orlando
29. JP Higgins SG Thompson JJ Deeks DG Altman 2003 Measuring inconsistency in meta-analyses BMJ 327 557 560 10.1136/bmj.327.7414.557 12958120
30. PJ Huber 1967 The behavior of maximum likelihood estimates under non-standard conditions Proc Fifth Berkeley Symp Math Stat Probab 1 221 233
31. Hunter JE, Schmidt FL (1990) Methods of meta-analysis: correcting error and bias in research findings. Sage, Newbury Park
32. HC Kraemer DJ Kupfer 2006 Size of treatment effects and their importance to clinical research and practice Biol Psychiatry 59 990 996 10.1016/j.biopsych.2005.09.014 16368078 (Pubitemid 43849650)
33. MJ Manos EJ Short RL Findling 1999 Differential effectiveness of methylphenidate and Adderall in school-age youths with attention-deficit/ hyperactivity disorder J Am Acad Child Adolesc Psychiatry 38 813 819 10.1097/00004583-199907000-00010 1:STN:280:DyaK1Mzjtlyrtw%3D%3D 10405498 (Pubitemid 29309840)
34. KO Mcgraw SP Wong 1992 A common language effect size statistic Psychol Bull 111 361 365 10.1037/0033-2909.111.2.361
35. KS Patrick RW Caldwell RM Ferris GR Breese 1987 Pharmacology of the enantiomers of threo-methylphenidate J Pharmacol Exp Ther 241 152 158 1:CAS:528:DyaL2sXktFOksro%3D 3572779
36. W Pelham K Greenslade M Vodde-Hamilton D Murphy J Greenstein E Gnagy K Guthrie M Hoover R Dahl 1990 Relative efficacy of long-acting stimulants on children with attention deficit-hyperactivity disorder: a comparison of standard methylphenidate, sustained-release methylphenidate, sustained-release dextroamphetamine, and pemoline Pediatrics 86 226 237 2196522
37. SR Pliszka RG Browne RL Olvera SK Wynne 2000 A double-blind, placebo-controlled study of Adderall and methylphenidate in the treatment of attention-deficit/hyperactivity disorder J Am Acad Child Adolesc Psychiatry 39 619 626 10.1097/00004583-200005000-00016 1:STN:280:DC%2BD3c3mt1ehtw%3D%3D 10802980
38. HM Schachter B Pham J King S Langford D Moher 2001 How efficacious and safe is short-acting methylphenidate for the treatment of attention-deficit disorder in children and adolescents? A meta-analysis CMAJ 165 1475 1488 1:STN:280:DC%2BD38%2Fjs1eitg%3D%3D 11762571
39. LS Seiden KE Sabol GA Ricaurte 1993 Amphetamine: effects on catecholamine systems and behavior Annu Rev Pharmacol Toxicol 33 639 677 10.1146/annurev.pa. 33.040193.003231 1:CAS:528:DyaK3sXks1aitLc%3D 8494354
40. EJ Short MJ Manos RL Findling EA Schubel 2004 A prospective study of stimulant response in preschool children: insights from ROC analyses J Am Acad Child Adolesc Psychiatry 43 251 259 10.1097/00004583-200403000-00005 15076257 (Pubitemid 41615003)
41. T Spencer J Biederman T Wilens 2000 Pharmacotherapy of attention deficit hyperactivity disorder Child Adolesc Psychiatr Clin N Am 9 77 97 1:STN:280:DC%2BD3c7jvFWntA%3D%3D 10674191 (Pubitemid 30261719)
42. Stata Corporation (2001) Stata user's guide: release 7.0. Stata Corporation, College Station
43. JE Thornburg KE Moore 1973 The relative importance of dopaminergic and noradrenergic neuronal systems for the stimulation of locomotor activity induced by amphetamine and other drugs Neuropharmacology 12 853 866 10.1016/0028-3908(73)90038-5 1:CAS:528:DyaE3sXlsVaqsLc%3D 4147726
44. J Tiihonen T Hallikainen OP Ryynanen E Repo-Tiihonen I Kotilainen M Eronen P Toivonen K Wahlbeck A Putkonen 2003 Lamotrigine in treatment-resistant schizophrenia: a randomized placebo-controlled crossover trial Biol Psychiatry 54 1241 1248 10.1016/S0006-3223(03)00524-9 1:CAS:528:DC%2BD3sXpt1Whsr8%3D 14643092 (Pubitemid 37464870)
45. ND Volkow JS Fowler G Wang Y Ding SJ Gatley 2002 Mechanism of action of methylphenidate: insights from PET imaging studies J Atten Disord 6 S31 S43 12685517
46. ND Volkow G Wang JS Fowler J Logan M Gerasimov L Maynard Y Ding SJ Gatley A Gifford D Franceschi 2001 Therapeutic doses of oral methylphenidate significantly increase extracellular dopamine in the human brain J Neurosci 21 RC121 1:STN:280:DC%2BD3M7psFKnsA%3D%3D 11160455
47. ®) in the treatment of adolescents with attention-deficit/hyperactivity disorder Arch Pediatr Adolesc Med 160 82 90 10.1001/archpedi.160.1.82 16389216 (Pubitemid 43042140)
48. HK Wilson DJ Cox RL Merkel M Moore D Coghill 2006 Effect of extended release stimulant-based medications on neuropsychological functioning among adolescents with attention-deficit/hyperactivity disorder Arch Clin Neuropsychol 21 797 807 10.1016/j.acn.2006.06.016 17049803 (Pubitemid 44693173)
49. M Wolraich LL Greenhill W Pelham J Swanson T Wilens D Palumbo M Atkins K Mcburnett O Bukstein G August 2001 Randomized controlled trial of OROS methylphenidate qd in children with attention deficit/hyperactivity disorder Pediatrics 108 883 892 10.1542/peds.108.4.883 1:STN:280:DC%2BD3MrjsVKjsw%3D%3D 11581440 (Pubitemid 32947657)
50. P Zeiner G Bryhn C Bjercke K Truyen G Strand 1999 Response to methylphenidate in boys with attention-deficit hyperactivity disorder Acta Paediatr 88 298 303 10.1080/08035259950170060 1:STN:280:DyaK1M3ksVSntQ%3D%3D 10229041 (Pubitemid 29144137)